• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532649
INE023H01027
29.975455
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NECLIFE
0
206.5
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

infosys ltd
TTK Healthcare standalone net profit rises 34.74% in the March 2026 quarter
Jun 01,2026
Net profit of TTK Healthcare rose 34.74% to Rs 21.76 crore in the quarter ended March 2026 as against Rs 16.15 crore during the previous quarter ended March 2025. Sales rose 14.51% to Rs 217.98 crore in the quarter ended March 2026 as against Rs 190.36 crore during the previous quarter ended March 2025.

For the full year,net profit declined 19.57% to Rs 65.68 crore in the year ended March 2026 as against Rs 81.66 crore during the previous year ended March 2025. Sales rose 6.96% to Rs 857.28 crore in the year ended March 2026 as against Rs 801.49 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales217.98190.36 15 857.28801.49 7
OPM %5.066.30 -3.054.34 -
PBDT28.1629.79 -5 95.39102.75 -7
PBT26.0227.62 -6 86.6394.42 -8
NP21.7616.15 35 65.6881.66 -20